Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Non/invasive
Recent news which mentions Non/invasive
OncoBeta introduces Rhenium-SCT for non-melanoma skin cancer patients at Hospital Universitario 12 de Octubre
June 20, 2024
Tags
Skin Cancer Treatment
Munich
Spain
From
PRLog
GenesisCare and OncoBeta announce partnership to provide innovative treatment for non-melanoma skin cancer
May 17, 2023
Tags
Basal Cell Carcinoma
Australia
Germany
From
PRLog
Latest research shows Australians still not getting annual skin checks with a Health Professional
March 01, 2023
Tags
Non/invasive
NMSC therapy
Non/melanoma skin cancer
From
PRLog
London skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
September 27, 2022
Tags
Skin Cancer Therapy
Medical
Science
From
PRLog
German skin cancer patients join the EPIC-Skin study
July 28, 2022
Tags
Mecklenburg/Vorpommern
EPIC/Skin
Health
From
PRLog
Sydney skin cancer patients join the EPIC-Skin study as they undergo first treatments with OncoBeta's Rhenium-SCT
April 13, 2022
Tags
Sydney
Non/invasive
Non/melanoma skin cancer
From
PRLog
EPIC-Skin study welcomes world-first skin cancer patients treated with OncoBeta's Rhenium-SCT
March 10, 2022
Tags
Bavaria
Health
EPIC/Skin
From
PRLog
OncoBeta receives ethics approval for EPIC-Skin study to evaluate Rhenium-SCT in Australia
December 21, 2021
Tags
Beauty
Bavaria
Health
From
PRLog
South African non-melanoma skin cancer patients now have greater access in the area of Johannesburg to innovative non-invasive treatment Rhenium-SCT®
November 16, 2021
Tags
Research
Single/session
Munich
From
PRLog
Australian Nuclear Science and Technology Organization (ANSTO), the new production partner of OncoBeta® GmbH in Australia
July 13, 2021
Tags
NMSC therapy
Non/invasive
Sydney
From
PRLog
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.